Beth Weinberg

Beth Weinberg is a Pharmacist with over 27 years of drug development experience. She began her career at Eli Lilly and Company in Clinical Development and had roles of increasing responsibility in Clinical Operations/Development and Medical Affairs. She found her passion in Regulatory Affairs and spent 13 years there before retiring from Lilly in 2018. She joined Metavant Sciences as VP and Head of Regulatory Affairs and Quality, moved to Roivant as VP and Head of Regulatory and to Angion Biomedica as VP of Regulatory Affairs. Beth has strong therapeutic expertise in diabetes, metabolism, cardiovascular disease, renal diseases, and inflammation/autoimmune disorders. She has led or been involved in more than 20 INDs, NDAs, BLAs and ex-US regulatory submissions and has led dozens of regulatory authority interactions. Beth holds a BA in Liberal Arts from Bradley University and a BSPharm from Butler University.